The Microbiome and Biomarkers for Necrotizing Enterocolitis: Are We Any Closer to Prediction?

Journal of Pediatrics

Volumn 189, Issue , 2017, Pages 40-47.e2

  Rusconi, Brigida ^a   Good, Misty ^a   Warner, Barbara B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gut; infant; preterm; spontaneous intestinal perforation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; MATRILYSIN;

ARTICLE; BACTERIAL COLONIZATION; DYSBIOSIS; ESCHERICHIA COLI; GAMMAPROTEOBACTERIA; HUMAN; INFANT; INTESTINE FLORA; KLEBSIELLA; METABOLOMICS; MICROBIOME; NECROTIZING ENTEROCOLITIS; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEOMICS; COMPARATIVE STUDY; FEMALE; MALE; METABOLISM; MICROBIOLOGY; NEWBORN; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; UNITED STATES;

BIOMARKERS; ENTEROCOLITIS, NECROTIZING; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 85021373338     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.05.075     Document Type: Article

References (135)

1. Patel, R.M., Kandefer, S., Walsh, M.C., Bell, E.F., Carlo, W.A., Laptook, A.R., et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 372 (2015), 331–340.
2. Stoll, B.J., Hansen, N.I., Bell, E.F., Walsh, M.C., Carlo, W.A., Shankaran, S., et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314 (2015), 1039–1051.
3. Pourcyrous, M., Korones, S.B., Yang, W., Boulden, T.F., Bada, H.S., C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics 116 (2005), 1064–1069.
4. Srinivasjois, R., Nathan, E., Doherty, D., Patole, S., Prediction of progression of definite necrotising enterocolitis to need for surgery or death in preterm neonates. J Matern Fetal Neonatal Med 23 (2010), 695–700.
5. Kim, D., Fu, C., Ling, X.B., Hu, Z., Tao, G., Zhao, Y., et al. Pilot application of magnetic nanoparticle-based biosensor for necrotizing enterocolitis. J Proteomics Bioinform(suppl 5), 2015, 002.
6. Cetinkaya, M., Ozkan, H., Koksal, N., Akaci, O., Ozgur, T., Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg 46 (2011), 1482–1489.
7. Isaacs, D., North, J., Lindsell, D., Wilkinson, A.R., Serum acute phase reactants in necrotizing enterocolitis. Acta Paediatr Scand 76 (1987), 923–927.
8. Keane, M., Fallon, R., Riordan, A., Shaw, B., Markedly raised levels of C-reactive protein are associated with culture-proven sepsis or necrotising enterocolitis in extremely preterm neonates. Acta Paediatr 104 (2015), e289–93.
9. Shah, B.A., Migliori, A., Kurihara, I., Sharma, S., Lim, Y.-P., Padbury, J., Blood level of inter-alpha inhibitor proteins distinguishes necrotizing enterocolitis from spontaneous intestinal perforation. J Pediatr 180 (2017), 135–140 e1.
10. Edelson, M.B., Bagwell, C.E., Rozycki, H.J., Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103 (1999), 766–771.
11. Harris, M.C., D'Angio, C.T., Gallagher, P.R., Kaufman, D., Evans, J., Kilpatrick, L., Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr 147 (2005), 462–468.
12. Ng, P.C., Li, K., Wong, R.P., Chui, K., Wong, E., Li, G., et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 88 (2003), F209–13.
13. Sharma, R., Tepas, J.J. 3rd, Hudak, M.L., Mollitt, D.L., Wludyka, P.S., Teng, R.J., et al. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 42 (2007), 454–461.
14. Maheshwari, A., Schelonka, R.L., Dimmitt, R.A., Carlo, W.A., Munoz-Hernandez, B., Das, A., et al. Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res 76 (2014), 100–108.
15. Benkoe, T., Reck, C., Pones, M., Weninger, M., Gleiss, A., Stift, A., et al. Interleukin-8 predicts 60-day mortality in premature infants with necrotizing enterocolitis. J Pediatr Surg 49 (2014), 385–389.
16. Murgas Torrazza, R., Li, N., Young, C., Kobeissy, F., Chow, M., Chen, S., et al. Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology 104 (2013), 234–242.
17. Wilcock, A., Begley, P., Stevens, A., Whatmore, A., Victor, S., The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study. J Matern Fetal Neonatal Med 29 (2016), 758–762.
18. Benkoe, T.M., Mechtler, T.P., Weninger, M., Pones, M., Rebhandl, W., Kasper, D.C., Serum levels of interleukin-8 and gut-associated biomarkers in diagnosing necrotizing enterocolitis in preterm infants. J Pediatr Surg 49 (2014), 1446–1451.
19. Amer, M.D., Hedlund, E., Rochester, J., Caplan, M.S., Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate 85 (2004), 159–166.
20. Rabinowitz, S.S., Dzakpasu, P., Piecuch, S., Leblanc, P., Valencia, G., Kornecki, E., Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr 138 (2001), 81–86.
21. Carroll, D., Corfield, A., Spicer, R., Cairns, P., Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet 361 (2003), 310–311.
22. Aydemir, O., Aydemir, C., Sarikabadayi, Y.U., Emre Canpolat, F., Erdeve, O., Biyikli, Z., et al. Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med 25 (2012), 2237–2241.
23. Bin-Nun, A., Booms, C., Sabag, N., Mevorach, R., Algur, N., Hammerman, C., Rapid fecal calprotectin (FC) analysis: point of care testing for diagnosing early necrotizing enterocolitis. Am J Perinatol 32 (2015), 337–342.
24. Zhang, M., Zhang, X., Zhang, J., Diagnostic value of fecal calprotectin in preterm infants with necrotizing enterocolitis. Clin Lab 62 (2016), 863–869.
25. Zoppelli, L., Guttel, C., Bittrich, H.J., Andree, C., Wirth, S., Jenke, A., Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology 102 (2012), 68–74.
26. Evennett, N.J., Hall, N.J., Pierro, A., Eaton, S., Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 45 (2010), 735–740.
27. Derikx, J.P., Evennett, N.J., Degraeuwe, P.L., Mulder, T.L., van Bijnen, A.A., van Heurn, L.W., et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 56 (2007), 1473–1475.
28. Guthmann, F., Borchers, T., Wolfrum, C., Wustrack, T., Bartholomaus, S., Spener, F., Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 239 (2002), 227–234.
29. Ng, P.C., Ang, I.L., Chiu, R.W., Li, K., Lam, H.S., Wong, R.P., et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 120 (2010), 2989–3000.
30. Thuijls, G., Derikx, J.P., van Wijck, K., Zimmermann, L.J., Degraeuwe, P.L., Mulder, T.L., et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 251 (2010), 1174–1180.
31. Reisinger, K.W., Van der Zee, D.C., Brouwers, H.A., Kramer, B.W., van Heurn, L.W., Buurman, W.A., et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 47 (2012), 1640–1645.
32. Ng, E.W., Poon, T.C., Lam, H.S., Cheung, H.M., Ma, T.P., Chan, K.Y., et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 258 (2013), 1111–1118.
33. Sylvester, K.G., Ling, X.B., Liu, G.Y., Kastenberg, Z.J., Ji, J., Hu, Z., et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr 164 (2014), 607–612 e1-7.
34. Sylvester, K.G., Ling, X.B., Liu, G.Y., Kastenberg, Z.J., Ji, J., Hu, Z., et al. A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants. Gut 63 (2014), 1284–1292.
35. Stewart, C.J., Nelson, A., Treumann, A., Skeath, T., Cummings, S.P., Embleton, N.D., et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis. Pediatr Res 79 (2016), 425–431.
36. Amin, H.J., Zamora, S.A., McMillan, D.D., Fick, G.H., Butzner, J.D., Parsons, H.G., et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 140 (2002), 425–431.
37. Tubman, T.R., Thompson, S.W., McGuire, W., Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev(1), 2008 CD001457.
38. Zamora, S.A., Amin, H.J., McMillan, D.D., Kubes, P., Fick, G.H., Butzner, J.D., et al. Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr 131 (1997), 226–232.
39. Richir, M.C., Siroen, M.P., van Elburg, R.M., Fetter, W.P., Quik, F., Nijveldt, R.J., et al. Low plasma concentrations of arginine and asymmetric dimethylarginine in premature infants with necrotizing enterocolitis. Br J Nutr 97 (2007), 906–911.
40. Celik, I.H., Demirel, G., Canpolat, F.E., Dilmen, U., Reduced plasma citrulline levels in low birth weight infants with necrotizing enterocolitis. J Clin Lab Anal 27 (2013), 328–332.
41. Ioannou, H.P., Diamanti, E., Piretzi, K., Drossou-Agakidou, V., Augoustides-Savvopoulou, P., Plasma citrulline levels in preterm neonates with necrotizing enterocolitis. Early Hum Dev 88 (2012), 563–566.
42. Jiang, P., Smith, B., Qvist, N., Nielsen, C., Wan, J.M., Sit, W.H., et al. Intestinal proteome changes during infant necrotizing enterocolitis. Pediatr Res 73 (2013), 268–276.
43. Stewart, C.J., Embleton, N.D., Marrs, E.C., Smith, D.P., Nelson, A., Abdulkadir, B., et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome, 4, 2016, 67.
44. Sylvester, K.G., Kastenberg, Z.J., Moss, R.L., Enns, G.M., Cowan, T.M., Shaw, G.M., et al. Acylcarnitine profiles reflect metabolic vulnerability for necrotizing enterocolitis in newborns born premature. J Pediatr 181 (2017), 80–85 e1.
45. Tao, G.Z., Liu, B., Zhang, R., Liu, G., Abdullah, F., Harris, M.C., et al. Impaired activity of blood coagulant factor XIII in patients with necrotizing enterocolitis. Sci Rep, 5, 2015, 13119.
46. Claud, E.C., Walker, W.A., Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 15 (2001), 1398–1403.
47. Young, C., Sharma, R., Handfield, M., Mai, V., Neu, J., Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention?. Pediatr Res 65 (2009), 91R–97R.
48. Neu, J., Pammi, M., Pathogenesis of NEC: impact of an altered intestinal microbiome. Semin Perinatol 41 (2016), 29–35.
49. Warner, B.B., Tarr, P.I., Necrotizing enterocolitis and preterm infant gut bacteria. Semin Fetal Neonatal Med 21 (2016), 394–399.
50. Morrow, A.L., Lagomarcino, A.J., Schibler, K.R., Taft, D.H., Yu, Z., Wang, B., et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome, 1, 2013, 13.
51. Garner, C.E., Ewer, A.K., Elasouad, K., Power, F., Greenwood, R., Ratcliffe, N.M., et al. Analysis of faecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study. J Pediatr Gastroenterol Nutr 49 (2009), 559–565.
52. de Meij, T.G., van der Schee, M.P., Berkhout, D.J., van de Velde, M.E., Jansen, A.E., Kramer, B.W., et al. Early detection of necrotizing enterocolitis by fecal volatile organic compounds analysis. J Pediatr 167 (2015), 562–567 e1.
53. Gibson, M.K., Wang, B., Ahmadi, S., Burnham, C.A., Tarr, P.I., Warner, B.B., et al. Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome. Nat Microbiol, 1, 2016, 16024.
54. Ward, D.V., Scholz, M., Zolfo, M., Taft, D.H., Schibler, K.R., Tett, A., et al. Metagenomic sequencing with strain-level resolution implicates uropathogenic E. coli in necrotizing enterocolitis and mortality in preterm infants. Cell Rep 14 (2016), 2912–2924.
55. Jacquot, A., Neveu, D., Aujoulat, F., Mercier, G., Marchandin, H., Jumas-Bilak, E., et al. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J Pediatr 158 (2011), 390–396.
56. La Rosa, P.S., Warner, B.B., Zhou, Y., Weinstock, G.M., Sodergren, E., Hall-Moore, C.M., et al. Patterned progression of bacterial populations in the premature infant gut. Proc Natl Acad Sci USA 111 (2014), 12522–12527.
57. Normann, E., Fahlen, A., Engstrand, L., Lilja, H.E., Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr 102 (2013), 129–136.
58. Sim, K., Shaw, A.G., Randell, P., Cox, M.J., McClure, Z.E., Li, M.S., et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis 60 (2015), 389–397.
59. Torrazza, R.M., Ukhanova, M., Wang, X., Sharma, R., Hudak, M.L., Neu, J., et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS ONE, 8, 2013 e83304.
60. Zhou, Y., Shan, G., Sodergren, E., Weinstock, G., Walker, W.A., Gregory, K.E., Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case-control study. PLoS ONE, 10, 2015 e0118632.
61. Mai, V., Young, C.M., Ukhanova, M., Wang, X., Sun, Y., Casella, G., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE, 6, 2011 e20647.
62. McMurtry, V.E., Gupta, R.W., Tran, L., Blanchard, E.E. 4th, Penn, D., Taylor, C.M., et al. Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis. Microbiome, 3, 2015, 11.
63. Warner, B.B., Deych, E., Zhou, Y., Hall-Moore, C., Weinstock, G.M., Sodergren, E., et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 387 (2016), 1928–1936.
64. Pammi, M., Cope, J., Tarr, P.I., Warner, B.B., Morrow, A.L., Mai, V., et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome, 5, 2017, 31.
65. Hodzic, Z., Bolock, A.M., Good, M., The role of mucosal immunity in the pathogenesis of necrotizing enterocolitis. Front Pediatr, 5, 2017, 40.
66. Egan, C.E., Sodhi, C.P., Good, M., Lin, J., Jia, H., Yamaguchi, Y., et al. Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. J Clin Invest 126 (2016), 495–508.
67. Good, M., Sodhi, C.P., Egan, C.E., Afrazi, A., Jia, H., Yamaguchi, Y., et al. Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol 8 (2015), 1166–1179.
68. Good, M., Sodhi, C.P., Ozolek, J.A., Buck, R.H., Goehring, K.C., Thomas, D.L., et al. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. Am J Physiol Gastrointest Liver Physiol 306 (2014), G1021–32.
69. Good, M., Sodhi, C.P., Hackam, D.J., Evidence-based feeding strategies before and after the development of necrotizing enterocolitis. Expert Rev Clin Immunol 10 (2014), 875–884.
70. Jia, H., Sodhi, C.P., Yamaguchi, Y., Lu, P., Martin, L.Y., Good, M., et al. Pulmonary epithelial TLR4 activation leads to lung injury in neonatal necrotizing enterocolitis. J Immunol 197 (2016), 859–871.
71. Nino, D.F., Sodhi, C.P., Egan, C.E., Zhou, Q., Lin, J., Lu, P., et al. Retinoic acid improves incidence and severity of necrotizing enterocolitis by lymphocyte balance restitution and repopulation of LGR5+ intestinal stem cells. Shock 47 (2017), 22–32.
72. Good, M., Sodhi, C.P., Yamaguchi, Y., Jia, H., Lu, P., Fulton, W.B., et al. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br J Nutr 116 (2016), 1175–1187.
73. Jensen, M.L., Thymann, T., Cilieborg, M.S., Lykke, M., Molbak, L., Jensen, B.B., et al. Antibiotics modulate intestinal immunity and prevent necrotizing enterocolitis in preterm neonatal piglets. Am J Physiol Gastrointest Liver Physiol 306 (2014), G59–71.
74. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, Y.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
75. Rios-Covian, D., Ruas-Madiedo, P., Margolles, A., Gueimonde, M., de Los Reyes-Gavilan, C.G., Salazar, N., Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol, 7, 2016, 185.
76. Kaiko, G.E., Ryu, S.H., Koues, O.I., Collins, P.L., Solnica-Krezel, L., Pearce, E.J., et al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 165 (2016), 1708–1720.
77. Buijck, M., Berkhout, D.J., de Groot, E.F., Benninga, M.A., van der Schee, M.P., Kneepkens, C.M., et al. Sniffing out paediatric gastrointestinal diseases: the potential of volatile organic compounds as biomarkers for disease. J Pediatr Gastroenterol Nutr 63 (2016), 585–591.
78. Harris, M.C., Costarino, A.T. Jr, Sullivan, J.S., Dulkerian, S., McCawley, L., Corcoran, L., et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 124 (1994), 105–111.
79. Gollin, G., Marks, C., Marks, W.H., Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery 113 (1993), 545–551.
80. Gollin, G., Stadie, D., Mayhew, J., Slater, L., Asmerom, Y., Boskovic, D., et al. Early detection of impending necrotizing enterocolitis with urinary intestinal fatty acid-binding protein. Neonatology 106 (2014), 195–200.
81. Gregory, K.E., Winston, A.B., Yamamoto, H.S., Dawood, H.Y., Fashemi, T., Fichorova, R.N., et al. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. J Pediatr 164 (2014), 1486–1488.
82. Mannoia, K., Boskovic, D.S., Slater, L., Plank, M.S., Angeles, D.M., Gollin, G., Necrotizing enterocolitis is associated with neonatal intestinal injury. J Pediatr Surg 46 (2011), 81–85.
83. Heida, F.H., Hulscher, J.B., Schurink, M., Timmer, A., Kooi, E.M., Bos, A.F., et al. Intestinal fatty acid-binding protein levels in necrotizing enterocolitis correlate with extent of necrotic bowel: results from a multicenter study. J Pediatr Surg 50 (2015), 1115–1118.
84. Schurink, M., Kooi, E.M., Hulzebos, C.V., Kox, R.G., Groen, H., Heineman, E., et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS ONE, 10, 2015 e0121336.
85. Selimoglu, M.A., Temel, I., Yildirim, C., Ozyaln, F., Aktas, M., Karabiber, H., The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis. Pediatr Crit Care Med 13 (2012), 452–454.
86. Reisinger, K.W., Kramer, B.W., Van der Zee, D.C., Brouwers, H.A., Buurman, W.A., van Heurn, E., et al. Non-invasive serum amyloid A (SAA) measurement and plasma platelets for accurate prediction of surgical intervention in severe necrotizing enterocolitis (NEC). PLoS ONE, 9, 2014 e90834.
87. Sho, S., Neal, M.D., Sperry, J., Hackam, D.J., A novel scoring system to predict the development of necrotizing enterocolitis totalis in premature infants. J Pediatr Surg 49 (2014), 1053–1056.
88. Tayman, C., Tonbul, A., Kahveci, H., Uysal, S., Koseoglu, B., Tatli, M.M., et al. C5a, a complement activation product, is a useful marker in predicting the severity of necrotizing enterocolitis. Tohoku J Exp Med 224 (2011), 143–150.
89. Halpern, M.D., Dvorak, B., Does abnormal bile acid metabolism contribute to NEC?. Semin Perinatol 32 (2008), 114–121.
90. Hulzebos, C.V., van Zoonen, A.G., Hulscher, J.B., Schat, T.E., Kooi, E.M., Koehorst, M., et al. Fecal bile salts and the development of necrotizing enterocolitis in preterm infants. PLoS ONE, 12, 2017 e0168633.
91. Out, C., Patankar, J.V., Doktorova, M., Boesjes, M., Bos, T., de Boer, S., et al. Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4. J Hepatol 63 (2015), 697–704.
92. Matt, P., Fu, Z., Fu, Q., Van Eyk, J.E., Biomarker discovery: proteome fractionation and separation in biological samples. Physiol Genomics 33 (2008), 12–17.
93. Vernocchi, P., Del Chierico, F., Putignani, L., Gut microbiota profiling: metabolomics based approach to unravel compounds affecting human health. Front Microbiol, 7, 2016, 1144.
94. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., Tanabe, M., KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44 (2016), D457–62.
95. Tuohy, K.M., Gougoulias, C., Shen, Q., Walton, G., Fava, F., Ramnani, P., Studying the human gut microbiota in the trans-omics era—focus on metagenomics and metabonomics. Curr Pharm Des 15 (2009), 1415–1427.
96. Marques, T.M., Wall, R., O'Sullivan, O., Fitzgerald, G.F., Shanahan, F., Quigley, E.M., et al. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. Br J Nutr 113 (2015), 728–738.
97. Abdel Hadi, L., Di Vito, C., Riboni, L., Fostering inflammatory bowel disease: sphingolipid strategies to join forces. Mediators Inflamm, 2016, 2016, 3827684.
98. Fritsche, K.L., The science of fatty acids and inflammation. Adv Nutr 6 (2015), 293S–301S.
99. Kunisawa, J., Kiyono, H., Sphingolipids and epoxidized lipid metabolites in the control of gut immunosurveillance and allergy. Front Nutr, 3, 2016, 3.
100. Peng, L., He, Z., Chen, W., Holzman, I.R., Lin, J., Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 61 (2007), 37–41.
101. Michalak, A., Mosinska, P., Fichna, J., Polyunsaturated fatty acids and their derivatives: therapeutic value for inflammatory, functional gastrointestinal disorders, and colorectal cancer. Front Pharmacol, 7, 2016, 459.
102. Sandborn, W.J., Feagan, B.G., Wolf, D.C., D'Haens, G., Vermeire, S., Hanauer, S.B., et al. Ozanimod induction and maintenance treatment for ulcerative colitis. N Engl J Med 374 (2016), 1754–1762.
103. Tsai, H.C., Han, M.H., Sphingosine-1-Phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation. Drugs 76 (2016), 1067–1079.
104. Chan, K.Y., Leung, K.T., Tam, Y.H., Lam, H.S., Cheung, H.M., Ma, T.P., et al. Genome-wide expression profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in human intestinal tissues: dysregulation of functional pathways. Ann Surg 260 (2014), 1128–1137.
105. Ng, P.C., Chan, K.Y., Leung, K.T., Tam, Y.H., Ma, T.P., Lam, H.S., et al. Comparative MiRNA expressional profiles and molecular networks in human small bowel tissues of necrotizing enterocolitis and spontaneous intestinal perforation. PLoS ONE, 10, 2015 e0135737.
106. Chaaban, H., Shin, M., Sirya, E., Lim, Y.P., Caplan, M., Padbury, J.F., Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr 157 (2010), 757–761.
107. Kern, S.E., Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res 72 (2012), 6097–6101.
108. Ioannidis, J.P., Panagiotou, O.A., Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. JAMA 305 (2011), 2200–2210.
109. Mai, V., Young, C.M., Ukhanova, M., Wang, X., Sun, Y., Casella, G., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE, 6, 2011, e20647.
110. McMurtry, V.E., Gupta, R.W., Tran, L., Blanchard, E.E. IV, Penn, D., Taylor, C.M., et al. Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis. Microbiome, 3, 2015, 11.
111. Heida, F.H., van Zoonen, A.G., Hulscher, J.B., te Kiefte, B.J., Wessels, R., Kooi, E.M., et al. A necrotizing enterocolitis-associated gut microbiota is present in the meconium: results of a prospective study. Clin Infect Dis 62 (2016), 863–870.
112. Torrazza, R.M., Ukhanova, M., Wang, X., Sharma, R., Hudak, M.L., Neu, J., et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS ONE, 8, 2013, e83304.
113. Sim, K., Shaw, A.G., Randell, P., Cox, M.J., McClure, Z.E., Li, M.S., et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis 60 (2015), 389–397.
114. Stewart, C.J., Embleton, N.D., Marrs, E.C., Smith, D.P., Nelson, A., Abdulkadir, B., et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome, 4, 2016, 67.
115. Warner, B.B., Deych, E., Zhou, Y., Hall-Moore, C., Weinstock, G.M., Sodergren, E., et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 387 (2016), 1928–1936.
116. Zhou, Y., Shan, G., Sodergren, E., Weinstock, G., Walker, W.A., Gregory, K.E., Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case-control study. PLoS ONE, 10, 2015, e0118632.
117. Ward, D.V., Scholz, M., Zolfo, M., Taft, D.H., Schibler, K.R., Tett, A., et al. Metagenomic sequencing with strain-level resolution implicates uropathogenic E. coli in necrotizing enterocolitis and mortality in preterm infants. Cell Rep 14 (2016), 2912–2924.
118. Ng, P.C., Ang, I.L., Chiu, R.W., Li, K., Lam, H.S., Wong, R.P., et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 120 (2010), 2989–3000.
119. Murgas Torrazza, R., Li, N., Young, C., Kobeissy, F., Chow, M., Chen, S., et al. Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology 104 (2013), 234–242.
120. Sylvester, K.G., Ling, X.B., Liu, G.Y., Kastenberg, Z.J., Ji, J., Hu, Z., et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr 164 (2014), 607–612 e1-7.
121. Sylvester, K.G., Ling, X.B., Liu, G.Y., Kastenberg, Z.J., Ji, J., Hu, Z., et al. A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants. Gut 63 (2014), 1284–1292.
122. Stewart, C.J., Nelson, A., Treumann, A., Skeath, T., Cummings, S.P., Embleton, N.D., et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising enterocolitis and late-onset sepsis. Pediatr Res 79 (2016), 425–431.
123. Tao, G.Z., Liu, B., Zhang, R., Liu, G., Abdullah, F., Harris, M.C., et al. Impaired activity of blood coagulant factor XIII in patients with necrotizing enterocolitis. Sci Rep, 5, 2015, 13119.
124. Morrow, A.L., Lagomarcino, A.J., Schibler, K.R., Taft, D.H., Yu, Z., Wang, B., et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome, 1, 2013, 13.
125. Wilcock, A., Begley, P., Stevens, A., Whatmore, A., Victor, S., The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study. J Matern Fetal Neonatal Med 29 (2016), 758–762.
126. Mai, V., Young, C.M., Ukhanova, M., Wang, X., Sun, Y., Casella, G., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE, 6, 2011, e20647.
127. McMurtry, V.E., Gupta, R.W., Tran, L., Blanchard, E., Penn, D., Taylor, C.M., et al. Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis. Microbiome, 3, 2015, 11.
128. Raveh-Sadka, T., Thomas, B.C., Singh, A., Firek, B., Brooks, B., Castelle, C.J., et al. Gut bacteria are rarely shared by co-hospitalized premature infants, regardless of necrotizing enterocolitis development. Elife, 2015, 4 Mar 3.
129. Heida, F.H., van Zoonen, A.G., Hulscher, J.B., te Kiefte, B.J., Wessels, R., Kooi, E.M., et al. A necrotizing enterocolitis-associated gut microbiota is present in the meconium: results of a prospective study. Clin Infect Dis 62 (2016), 863–870.
130. Torrazza, R.M., Ukhanova, M., Wang, X., Sharma, R., Hudak, M.L., Neu, J., et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS ONE, 8, 2013, e83304.
131. Ward, D.V., Scholz, M., Zolfo, M., Taft, D.H., Schibler, K.R., Tett, A., et al. Metagenomic sequencing with strain-level resolution implicates uropathogenic E. coli in necrotizing enterocolitis and mortality in preterm infants. Cell Rep 14 (2016), 2912–2924.
132. Zhou, Y., Shan, G., Sodergren, E., Weinstock, G., Walker, W.A., Gregory, K.E., Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case-control study. PLoS ONE, 10, 2015, e0118632.
133. Sim, K., Shaw, A.G., Randell, P., Cox, M.J., McClure, Z.E., Li, M.S., et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis 60 (2015), 389–397.
134. Stewart, C.J., Embleton, N.D., Marrs, E.C., Smith, D.P., Nelson, A., Abdulkadir, B., et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome, 4, 2016, 67.
135. Warner, B.B., Deych, E., Zhou, Y., Hall-Moore, C., Weinstock, G.M., Sodergren, E., et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 387 (2016), 1928–1936.